Sarcoma

Top Story

FDA grants orphan drug designation to CLR 131 for Ewing sarcoma

July 10, 2018
In the Journals Plus

American Cancer Society creates blueprint to reduce cancer mortality by 2035

July 10, 2018
Researchers from the American Cancer Society identified trends in disparities and outcomes for cancer over the last few decades in an effort to highlight the need for…
In the Journals Plus

Rivaroxaban reduces VTE recurrence in patients with cancer

June 27, 2018
Rivaroxaban significantly reduced venous thromboembolism recurrence among patients who had cancer and VTE compared with dalteparin, according to findings published in…
In the Journals Plus

Childhood cancer survivors show lack of concern over future health

June 25, 2018
Thirty-one percent of adult survivors of childhood cancer reported a lack of concern for future health and 40% reported a lack of concern regarding risk for future…
More Headlines »
CME

EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of…
More »
Video

VIDEO: Toxicities related to immune therapies ‘unpredictable’ but ‘manageable’

June 23, 2016
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting

CME

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

The integration of immune checkpoint inhibitors into treatment algorithms for patients with bladder cancer who have…
More »